University of California San Francisco
Give to UCSFA Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to UCSF doctors who led the research.
Five distinguished UCSF scientists, including three Nobel laureates, are being inducted into the prestigious inaugural class of fellows of the American Association for Cancer Research Academy.
Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages, UCSF researchers have discovered.
<p>Ten years after the UCSF Mission Bay campus was established, UCSF Medical Center at Mission Bay – the key patient-care component of the campus – is only two years away from opening.</p>
Researchers have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug – an observation that may have important implications for the lives of patients with late-stage disease.
<p>The National Cancer Institute has awarded the UCSF Helen Diller Family Comprehensive Cancer Center a $36 million support grant that will fund infrastructure for clinical trials, cutting-edge research and programmatic support over five years.</p>
UC San Francisco's Jonathan Ostrem, PhD, and David Weinberg, PhD, have been acknowledged in Forbes magazine’s “30 under 30” list for their contributions to science and healthcare.
A team of UCSF researchers have conducted the most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness.
St. Joseph’s Medical Center is bringing advanced cancer care to San Joaquin County with a new collaboration between St. Joseph’s Regional Cancer Center and the UCSF Helen Diller Family Comprehensive Cancer Center that will enhance patient care and access to clinical trials.